Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (2) , 181-184
- https://doi.org/10.1016/0002-9343(90)90297-q
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Formation of Neutralizing Antibodies During Intranasal Synthetic Salmon Calcitonin Treatment of Paget's Disease*Journal of Clinical Endocrinology & Metabolism, 1988
- One year's treatment of paget's disease of bone by synthetic salmon calcitonin as a nasal sprayJournal of Bone and Mineral Research, 1988
- Intranasal Salmon Calcitonin Treatment of Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1988
- Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's diseaseCalcified Tissue International, 1987
- Synthetic Human Calcitonin in Refractory Paget's Disease of BoneArchives of internal medicine (1960), 1987
- Intranasal calcitonin and plasma calcium concentrations in normal subjects.BMJ, 1985
- Paget's disease of bone : the effect of stopping long term human calcitonin and recommendations for future treatmentMetabolic Bone Disease and Related Research, 1980
- PAGET'S BONE DISEASE: RESPONSE TO HUMAN CALCITONIN IN PATIENTS RESISTANT TO SALMON CALCITONINThe Lancet, 1974
- Calcitonin Resistance: Clinical and Immunologic Studies in Subjects with Paget's Disease of Bone Treated with Porcine and Salmon CalcitoninsJournal of Clinical Investigation, 1972
- An evaluation of antibodies and clinical resistance to salmon calcitoninJournal of Clinical Investigation, 1972